Continuous versus standard blood sugar monitoring in the ICU
Part of Hormones & metabolism clinical trials.
This trial is testing two ways of monitoring blood sugar in intensive care patients: continuous monitoring (a sensor) versus intermittent checks. If you are in the ICU with high blood sugar and on IV insulin, this study might help find a better way to manage your levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be admitted to an intensive care unit (ICU).
- Your blood sugar must be above 180 mg/dL (10 mmol/L) on at least two separate tests.
- You must be receiving insulin through an IV line.
- You are expected to stay in the ICU for at least 48 hours.
- You cannot be pregnant, have type 1 diabetes, severe skin disease, very low white blood cell count, or a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to monitor blood sugar in the intensive care unit (ICU) using a small sensor that sends readings wirelessly to the care team. If you have high blood sugar and are on insulin, this could help keep your levels more stable without frequent finger pricks.
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.